# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 21, "Diabetes Obes Metab .", "", "<http://ctro/data#Publication_80923> <http://ctro/data#hasJournal> \"Diabetes Obes Metab .\"."
1, PublicationYear, 22, 26, "2017", "", "<http://ctro/data#Publication_80923> <http://ctro/data#hasPublicationYear> \"2017\"."
10, Title, 110, 305, "Postprandial renal haemodynamic effect of lixisenatide vs once - daily insulin - glulisine in patients with type 2 diabetes on insulin - glargine : An 8 - week , randomised , open - label trial .", "", "<http://ctro/data#Publication_80923> <http://ctro/data#hasTitle> \"Postprandial renal haemodynamic effect of lixisenatide vs once - daily insulin - glulisine in patients with type 2 diabetes on insulin - glargine : An 8 - week , randomised , open - label trial .\"."
98984, Lixisenatide, 152, 164, "lixisenatide", "", 
4, Frequency, 168, 180, "once - daily", "", 
3, InsulinGlulisine, 181, 200, "insulin - glulisine", "", 
5, Type2Diabetes, 218, 233, "type 2 diabetes", "", 
6, InsulinGlargine, 237, 255, "insulin - glargine", "", 
7, Duration, 261, 269, "8 - week", "", "<http://ctro/data#ClinicalTrial_80938> <http://ctro/data#hasCTduration> \"8 - week\"."
8, Randomized, 272, 282, "randomised", "", "<http://ctro/data#ClinicalTrial_80938> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
9, OpenLabel, 285, 297, "open - label", "", "<http://ctro/data#ClinicalTrial_80938> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel>."
11, Author, 306, 317, "Tonneijck L", "", "<http://ctro/data#Publication_80923> <http://ctro/data#hasAuthor> \"Tonneijck L\"."
12, Author, 326, 337, "Muskiet MHA", "", "<http://ctro/data#Publication_80923> <http://ctro/data#hasAuthor> \"Muskiet MHA\"."
13, Author, 346, 354, "Smits MM", "", "<http://ctro/data#Publication_80923> <http://ctro/data#hasAuthor> \"Smits MM\"."
14, Author, 363, 373, "Hoekstra T", "", "<http://ctro/data#Publication_80923> <http://ctro/data#hasAuthor> \"Hoekstra T\"."
15, Author, 388, 398, "Kramer MHH", "", "<http://ctro/data#Publication_80923> <http://ctro/data#hasAuthor> \"Kramer MHH\"."
16, Author, 407, 417, "Danser AHJ", "", "<http://ctro/data#Publication_80923> <http://ctro/data#hasAuthor> \"Danser AHJ\"."
17, Author, 426, 435, "Diamant M", "", "<http://ctro/data#Publication_80923> <http://ctro/data#hasAuthor> \"Diamant M\"."
18, Author, 444, 452, "Joles JA", "", "<http://ctro/data#Publication_80923> <http://ctro/data#hasAuthor> \"Joles JA\"."
19, Author, 461, 474, "van Raalte DH", "", "<http://ctro/data#Publication_80923> <http://ctro/data#hasAuthor> \"van Raalte DH\"."
20, Netherlands, 605, 620, "The Netherlands", "", "<http://ctro/data#Population_80957> <http://ctro/data#hasCountry> <http://ctro/data#Netherlands>."
21, Netherlands, 751, 766, "The Netherlands", "", 
22, Netherlands, 865, 880, "The Netherlands", "", 
23, Netherlands, 1020, 1035, "The Netherlands", "", 
24, Netherlands, 1126, 1141, "The Netherlands", "", 
30, ObjectiveDescription, 1150, 1371, "To determine whether lixisenatide , a prandial short - acting glucagon - like peptide receptor agonist ( GLP - 1RA ) , ameliorates postprandial glomerular hyperfiltration in patients with type 2 diabetes mellitus ( T2DM )", "", "<http://ctro/data#ClinicalTrial_80938> <http://ctro/data#hasObjectiveDescription> \"To determine whether lixisenatide , a prandial short - acting glucagon - like peptide receptor agonist ( GLP - 1RA ) , ameliorates postprandial glomerular hyperfiltration in patients with type 2 diabetes mellitus ( T2DM )\"."
98989, Lixisenatide, 1171, 1183, "lixisenatide", "", 
26, Type2Diabetes, 1338, 1362, "type 2 diabetes mellitus", "", "<http://ctro/data#ClinicalTrial_80938> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes>."
27, Type2Diabetes, 1365, 1369, "T2DM", "", 
31, ObjectiveDescription, 1372, 1416, "compared with insulin - glulisine ( iGlu ) .", "", "<http://ctro/data#ClinicalTrial_80938> <http://ctro/data#hasObjectiveDescription> \"compared with insulin - glulisine ( iGlu ) .\"."
28, InsulinGlulisine, 1386, 1405, "insulin - glulisine", "", 
29, InsulinGlulisine, 1408, 1412, "iGlu", "", 
32, Duration, 1470, 1478, "8 - week", "", 
98988, Lixisenatide, 1494, 1506, "lixisenatide", "", "<http://ctro/data#Medication_83214> <http://ctro/data#hasDrug> <http://ctro/data#Lixisenatide>."
156, DoseValue, 1507, 1509, "20", "", "<http://ctro/data#Medication_83214> <http://ctro/data#hasDoseValue> \"20\"."
35, Microgram, 1510, 1513, "Âµ g", "", "<http://ctro/data#Medication_83214> <http://ctro/data#hasDoseUnit> <http://ctro/data#Microgram>."
36, Frequency, 1517, 1529, "once - daily", "", "<http://ctro/data#Intervention_83234> <http://ctro/data#hasFrequency> \"once - daily\"."
37, InsulinGlulisine, 1539, 1543, "iGlu", "", "<http://ctro/data#Medication_83221> <http://ctro/data#hasDrug> <http://ctro/data#InsulinGlulisine>."
38, NumberPatientsCT, 1561, 1563, "35", "", "<http://ctro/data#ClinicalTrial_80938> <http://ctro/data#hasNumberPatientsCT> \"35\"."
98996, Precondition, 1575, 1667, "patients with T2DM inadequately controlled on insulin - glargine , with or without metformin", "", "<http://ctro/data#Population_80957> <http://ctro/data#hasPrecondition> \"patients with T2DM inadequately controlled on insulin - glargine , with or without metformin\"."
40, Type2Diabetes, 1589, 1593, "T2DM", "", 
132, InsulinGlargine, 1621, 1639, "insulin - glargine", "", 
43, Metformin, 1658, 1667, "metformin", "", 
44, Mean, 1670, 1674, "mean", "", 
45, AvgAge, 1684, 1686, "62", "", "<http://ctro/data#Population_80957> <http://ctro/data#hasAvgAge> \"62\"."
46, HbA1c, 1699, 1704, "HbA1c", "", 
49, BaseLineValue, 1705, 1710, "8 . 0", "", 
47, Percentage, 1711, 1712, "%", "", 
50, SdDevBL, 1715, 1720, "0 . 9", "", 
48, Percentage, 1721, 1722, "%", "", 
98997, EndPointDescription, 1735, 1761, "glomerular filtration rate", "", 
98998, EndPointDescription, 1764, 1767, "GFR", "", 
55, BaseLineValue, 1770, 1772, "85", "", "<http://ctro/data#Outcome_83258> <http://ctro/data#hasBaselineValue> \"85\". <http://ctro/data#Outcome_83285> <http://ctro/data#hasBaselineValue> \"85\"."
56, SdDevBL, 1775, 1777, "12", "", "<http://ctro/data#Outcome_83258> <http://ctro/data#hasSdDevBL> \"12\". <http://ctro/data#Outcome_83285> <http://ctro/data#hasSdDevBL> \"12\"."
165, BioAndMedicalUnit, 1778, 1798, "mL / min / 1 . 73 m2", "", 
51, BioAndMedicalUnit, 1875, 1884, "mg / mmol", "", 
58, EndPointDescription, 1922, 1925, "GFR", "", 
171, EndPointDescription, 1951, 1978, "effective renal plasma flow", "", 
172, EndPointDescription, 1981, 1985, "ERPF", "", 
173, Insulin, 2007, 2013, "inulin", "", 
174, MeasurementDevice, 2164, 2179, "Gomez equations", "", 
59, InsulinGlulisine, 2206, 2210, "iGlu", "", 
98990, Lixisenatide, 2213, 2225, "lixisenatide", "", 
61, EndPointDescription, 2241, 2244, "GFR", "", "<http://ctro/data#EndPointDescription_83155> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_83154> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_83155>."
106262, DiffGroupAbsValue, 2247, 2254, "+ 0 . 1", "", "<http://ctro/data#DiffBetweenGroups_83318> <http://ctro/data#hasDiffGroupAbsValue> \"+ 0 . 1\"."
186, BioAndMedicalUnit, 2255, 2275, "mL / min / 1 . 73 m2", "", "<http://ctro/data#BioAndMedicalUnit_83157> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit>. <http://ctro/data#Endpoint_83154> <http://ctro/data#hasBaselineUnit> <http://ctro/data#BioAndMedicalUnit_83157>."
99000, ConfIntervalDiff, 2278, 2294, "95 % CI - 9 to 9", "", "<http://ctro/data#DiffBetweenGroups_83318> <http://ctro/data#hasConfIntervalDiff> \"95 % CI - 9 to 9\"."
63, EndPointDescription, 2301, 2305, "ERPF", "", "<http://ctro/data#EndPointDescription_83160> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_83159> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_83160>."
106263, DiffGroupAbsValue, 2308, 2312, "- 17", "", "<http://ctro/data#DiffBetweenGroups_83381> <http://ctro/data#hasDiffGroupAbsValue> \"- 17\"."
187, BioAndMedicalUnit, 2313, 2333, "mL / min / 1 . 73 m2", "", "<http://ctro/data#BioAndMedicalUnit_83162> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#BioAndMedicalUnit>. <http://ctro/data#Endpoint_83159> <http://ctro/data#hasBaselineUnit> <http://ctro/data#BioAndMedicalUnit_83162>."
99002, ConfIntervalDiff, 2336, 2346, "- 61 to 26", "", "<http://ctro/data#DiffBetweenGroups_83381> <http://ctro/data#hasConfIntervalDiff> \"- 61 to 26\"."
179, EndPointDescription, 2353, 2414, "other ( intra - ) renal haemodynamics or renal damage markers", "", "<http://ctro/data#EndPointDescription_83165> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_83164> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_83165>."
74, EndPointDescription, 2431, 2458, "fractional sodium excretion", "", "<http://ctro/data#EndPointDescription_83170> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_83169> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_83170>."
106265, DiffGroupAbsValue, 2461, 2469, "+ 0 . 25", "", "<http://ctro/data#DiffBetweenGroups_83444> <http://ctro/data#hasDiffGroupAbsValue> \"+ 0 . 25\"."
73, Percentage, 2470, 2471, "%", "", "<http://ctro/data#Endpoint_83169> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage>."
99004, ConfIntervalDiff, 2474, 2489, "0 . 09 - 0 . 41", "", "<http://ctro/data#DiffBetweenGroups_83444> <http://ctro/data#hasConfIntervalDiff> \"0 . 09 - 0 . 41\"."
75, EndPointDescription, 2498, 2508, "urinary pH", "", "<http://ctro/data#EndPointDescription_83175> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_83174> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_83175>."
106264, DiffGroupAbsValue, 2511, 2518, "+ 0 . 7", "", "<http://ctro/data#DiffBetweenGroups_83507> <http://ctro/data#hasDiffGroupAbsValue> \"+ 0 . 7\"."
99005, ConfIntervalDiff, 2521, 2534, "0 . 3 - 1 . 2", "", "<http://ctro/data#DiffBetweenGroups_83507> <http://ctro/data#hasConfIntervalDiff> \"0 . 3 - 1 . 2\"."
197, EndPointDescription, 2541, 2553, "Plasma renin", "", "<http://ctro/data#EndPointDescription_83180> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_83179> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_83180>."
198, EndPointDescription, 2556, 2572, "angiotensin - II", "", "<http://ctro/data#EndPointDescription_83185> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_83184> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_83185>."
199, EndPointDescription, 2577, 2588, "aldosterone", "", "<http://ctro/data#EndPointDescription_83190> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_83189> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_83190>."
200, ObservedResult, 2589, 2603, "were unchanged", "", "<http://ctro/data#Outcome_83516> <http://ctro/data#hasObservedResult> \"were unchanged\". <http://ctro/data#Outcome_83543> <http://ctro/data#hasObservedResult> \"were unchanged\". <http://ctro/data#Outcome_83570> <http://ctro/data#hasObservedResult> \"were unchanged\"."
98991, Lixisenatide, 2606, 2618, "Lixisenatide", "", 
81, InsulinGlulisine, 2623, 2627, "iGlu", "", 
85, HbA1c, 2636, 2641, "HbA1c", "", "<http://ctro/data#Endpoint_83194> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#HbA1c>."
86, Reduction, 2657, 2662, "0 . 8", "", "<http://ctro/data#Outcome_83597> <http://ctro/data#hasChangeValue> \"0 . 8\"."
88, Percentage, 2663, 2664, "%", "", 
94, SdDevChangeValue, 2667, 2672, "0 . 1", "", "<http://ctro/data#Outcome_83597> <http://ctro/data#hasSdDevChangeValue> \"0 . 1\"."
89, Percentage, 2673, 2674, "%", "", "<http://ctro/data#Endpoint_83194> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Percentage>."
87, Reduction, 2679, 2684, "0 . 6", "", "<http://ctro/data#Outcome_83624> <http://ctro/data#hasChangeValue> \"0 . 6\"."
90, Percentage, 2685, 2686, "%", "", 
95, SdDevChangeValue, 2689, 2694, "0 . 1", "", "<http://ctro/data#Outcome_83624> <http://ctro/data#hasSdDevChangeValue> \"0 . 1\"."
91, Percentage, 2695, 2696, "%", "", 
103, PostprandialBloodGlucose, 2720, 2740, "postprandial glucose", "", "<http://ctro/data#Endpoint_83199> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#PostprandialBloodGlucose>."
212, ObservedResult, 2741, 2750, "was lower", "", "<http://ctro/data#Outcome_83651> <http://ctro/data#hasObservedResult> \"was lower\"."
98992, Lixisenatide, 2756, 2768, "lixisenatide", "", 
92, PvalueDiff, 2771, 2780, "P = . 002", "", "<http://ctro/data#DiffBetweenGroups_83705> <http://ctro/data#hasPvalueDiff> \"P = . 002\"."
82, InsulinGlulisine, 2799, 2803, "iGlu", "", 
98993, Lixisenatide, 2806, 2818, "lixisenatide", "", 
93, BodyWeight, 2827, 2837, "bodyweight", "", "<http://ctro/data#Endpoint_83204> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#BodyWeight>."
217, Reduction, 2842, 2847, "1 . 4", "", "<http://ctro/data#Outcome_83714> <http://ctro/data#hasChangeValue> \"1 . 4\"."
100, Kg, 2848, 2850, "kg", "", "<http://ctro/data#Endpoint_83204> <http://ctro/data#hasBaselineUnit> <http://ctro/data#Kg>."
96, ConfIntervalChangeValue, 2853, 2871, "- 2 . 5 to - 0 . 2", "", "<http://ctro/data#Outcome_83714> <http://ctro/data#hasConfIntervalChangeValue> \"- 2 . 5 to - 0 . 2\"."
216, EndPointDescription, 2890, 2925, "postprandial mean arterial pressure", "", "<http://ctro/data#EndPointDescription_83210> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_83209> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_83210>."
218, Increment, 2930, 2931, "9", "", "<http://ctro/data#Outcome_83741> <http://ctro/data#hasChangeValue> \"9\"."
222, mmHg, 2932, 2937, "mm Hg", "", "<http://ctro/data#Endpoint_83209> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
97, ConfIntervalChangeValue, 2940, 2946, "4 - 14", "", "<http://ctro/data#Outcome_83741> <http://ctro/data#hasConfIntervalChangeValue> \"4 - 14\"."
104, Duration, 2966, 2978, "Eight - week", "", 
110, ConclusionComment, 2966, 3164, "Eight - week lixisenatide treatment does not affect postprandial ( intra - ) renal haemodynamics compared with iGlu when added to insulin - glargine in patients with T2DM without overt nephropathy .", "", "<http://ctro/data#ClinicalTrial_80938> <http://ctro/data#hasConclusionComment> \"Eight - week lixisenatide treatment does not affect postprandial ( intra - ) renal haemodynamics compared with iGlu when added to insulin - glargine in patients with T2DM without overt nephropathy .\"."
98994, Lixisenatide, 2979, 2991, "lixisenatide", "", 
83, InsulinGlulisine, 3077, 3081, "iGlu", "", 
105, InsulinGlargine, 3096, 3114, "insulin - glargine", "", 
106, Type2Diabetes, 3132, 3136, "T2DM", "", 
111, ConclusionComment, 3165, 3387, "Prolonged lixisenatide treatment has a sustained natriuretic effect , which is in contrast to previous reports on long - acting GLP - 1RA , reduces body weight and increases postprandial blood pressure compared with iGlu .", "", "<http://ctro/data#ClinicalTrial_80938> <http://ctro/data#hasConclusionComment> \"Prolonged lixisenatide treatment has a sustained natriuretic effect , which is in contrast to previous reports on long - acting GLP - 1RA , reduces body weight and increases postprandial blood pressure compared with iGlu .\"."
98995, Lixisenatide, 3175, 3187, "lixisenatide", "", 
107, BodyWeight, 3313, 3324, "body weight", "", 
108, BloodPressure, 3339, 3366, "postprandial blood pressure", "", 
84, InsulinGlulisine, 3381, 3385, "iGlu", "", 
112, PMID, 3523, 3531, "28449402", "", "<http://ctro/data#Publication_80923> <http://ctro/data#hasPMID> \"28449402\"."
